Compound Evidence File
#EC-2026-0750
Estradiol Cypionate
Filed under Injectable Oils. The bureau holds 180 laboratory returns for this compound from 56 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
56 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Feb 2026 | 26 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 10.0 | 10.0 | 22 Jan 2026 | 12 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Jan 2026 | 7 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 11 Feb 2026 | 21 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 28 Mar 2026 | 18 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Mar 2026 | 3 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 5 Nov 2025 | 24 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 22 Jun 2026 | 14 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Jan 2026 | 23 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Apr 2026 | 15 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 10.0 | 10.0 | 10.0 | 4 May 2026 | 19 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 10.0 | 10.0 | 10.0 | 18 May 2026 | 22 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 20 May 2026 | 11 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Apr 2026 | 28 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 18 Nov 2025 | 2 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 10.0 | 15 Apr 2026 | 7 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 5 Feb 2026 | 10 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 15 Apr 2026 | 27 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Apr 2026 | 13 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 8 Aug 2026 | 18 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Mar 2026 | 14 Aug 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 9.5 | 9.0 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.9 | 8.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 8.9 | 8.9 | 8.9 | 3 Jul 2025 | 3 Jul 2025 |
| TCICASE #VI-2026-0650 | X | 1 | 8.8 | 8.8 | 8.8 | 7 May 2025 | 7 May 2025 |
| Bfflist AMOCASE #VI-2026-0678 | X | 5 | 8.7 | 7.5 | 10.0 | 7 May 2025 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 8 | 8.6 | 6.2 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.6 | 7.4 | 9.9 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.2 | 6.9 | 9.7 | 25 May 2026 | 25 May 2026 |
| Champion PeptideCASE #VI-2026-0909 | X | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 | 21 May 2025 |
| LiliPeptideCASE #VI-2026-0695 | X | 13 | 7.4 | 5.5 | 9.9 | 6 May 2025 | 24 May 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 6 | 7.3 | 5.4 | 8.7 | 13 Feb 2025 | 24 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 3 | 7.3 | 6.9 | 7.9 | 2 Jul 2025 | 20 May 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 7.3 | 7.3 | 7.3 | 24 Apr 2025 | 24 Apr 2025 |
| NexaphCASE #VI-2026-0944 | X | 8 | 7.1 | 4.2 | 8.5 | 7 May 2025 | 21 May 2026 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.0 | 7.0 | 7.0 | 21 May 2025 | 21 May 2025 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 | 21 May 2025 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 6.7 | 6.1 | 7.3 | 2 Apr 2025 | 21 May 2026 |
| Paradigm PeptideCASE #VI-2026-0759 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jul 2025 | 3 Jul 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 1 | 6.7 | 6.7 | 6.7 | 2 Apr 2025 | 2 Apr 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 6.6 | 4.6 | 8.7 | 6 May 2025 | 20 May 2026 |
| YimeiCASE #VI-2026-0081 | X | 5 | 6.5 | 5.1 | 8.0 | 14 Jan 2025 | 19 Jan 2026 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 6.5 | 5.9 | 7.0 | 14 Jan 2025 | 20 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Jul 2025 | 2 Jul 2025 |
| OupeptideCASE #VI-2026-0435 | X | 4 | 6.3 | 4.5 | 7.1 | 11 Jun 2025 | 21 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 6.3 | 5.7 | 6.9 | 3 Jul 2025 | 20 May 2026 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 6.3 | 6.3 | 6.3 | 6 May 2025 | 6 May 2025 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 5 | 5.4 | 2.9 | 8.1 | 27 Feb 2025 | 21 May 2026 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 5.4 | 5.4 | 5.4 | 25 Apr 2025 | 25 Apr 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 3.8 | 3.8 | 3.8 | 14 Jan 2025 | 14 Jan 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 3 | 2.6 | 2.4 | 2.8 | 2 Apr 2025 | 24 May 2026 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 2.6 | 2.6 | 2.6 | 2 Jul 2025 | 2 Jul 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.4 | 0.4 | 0.4 | 7 May 2025 | 7 May 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
Open any subject to view the batch-level evidence for Estradiol Cypionate alone.